Cargando…

Knockdown of UbcH10 Enhances the Chemosensitivity of Dual Drug Resistant Breast Cancer Cells to Epirubicin and Docetaxel

Breast cancer is one of the most common and lethal cancers in women. As a hub gene involved in a diversity of tumors, the ubiquitin-conjugating enzyme H10 (UbcH10), may also play some roles in the genesis and development of breast cancer. In the current study, we found that the expression of UbcH10...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Cheng, Pan, Yun-Hao, Shan, Ming, Xu, Ming, Bao, Jia-Lin, Zhao, Li-Ming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2015
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4394443/ https://www.ncbi.nlm.nih.gov/pubmed/25739083 http://dx.doi.org/10.3390/ijms16034698

Ejemplares similares

Segregating out UbcH10's role in tumorigenesis
por: Short, Ben
Publicado: (2010)

UbcH10 overexpression may represent a marker of anaplastic thyroid carcinomas
por: Pallante, P, et al.
Publicado: (2005)

UbcH10 overexpression increases carcinogenesis and blocks ALLN susceptibility in colorectal cancer
por: Li, Shang-Ze, et al.
Publicado: (2014)

UbcH10 a Major Actor in Cancerogenesis and a Potential Tool for Diagnosis and Therapy
por: Presta, Ivan, et al.
Publicado: (2020)

Overexpression of UbcH10 alternates the cell cycle profile and accelerate the tumor proliferation in colon cancer
por: Fujita, Takeo, et al.
Publicado: (2009)

UbcH7 reactivity profile reveals Parkin and HHARI to be RING/HECT hybrids
por: Wenzel, Dawn M., et al.
Publicado: (2011)

Structural analysis of recombinant human ubiquitin-conjugating enzyme UbcH5c
por: Wu, Fangshu, et al.
Publicado: (2017)

Overexpression of the E2 ubiquitin–conjugating enzyme UbcH10 causes chromosome missegregation and tumor formation
por: van Ree, Janine H., et al.
Publicado: (2010)

Ubiquitin control of S phase: a new role for the ubiquitin conjugating enzyme, UbcH7
por: Whitcomb, Elizabeth A, et al.
Publicado: (2009)

Synergistic recruitment of UbcH7~Ub and phosphorylated Ubl domain triggers parkin activation
por: Condos, Tara EC, et al.
Publicado: (2018)

Structural insights into non-covalent ubiquitin activation of the cIAP1-UbcH5B∼ubiquitin complex
por: Patel, Amrita, et al.
Publicado: (2019)

Molecular Simulation Elaborating the Mechanism of 1β-Hydroxy Alantolactone Inhibiting Ubiquitin-Conjugating Enzyme UbcH5s
por: Xu, Youdong, et al.
Publicado: (2020)

KIAA0101 and UbcH10 interact to regulate non-small cell lung cancer cell proliferation by disrupting the function of the spindle assembly checkpoint
por: Lei, Han, et al.
Publicado: (2020)

Epigenetic downregulation of the ISG15–conjugating enzyme UbcH8 impairs lipolysis and correlates with poor prognosis in nasopharyngeal carcinoma
por: Zhou, Xiaoying, et al.
Publicado: (2015)

Targeting E2 ubiquitin-conjugating enzyme UbcH5c by small molecule inhibitor suppresses pancreatic cancer growth and metastasis
por: Qi, Simin, et al.
Publicado: (2022)

Structural Studies of HHARI/UbcH7∼Ub Reveal Unique E2∼Ub Conformational Restriction by RBR RING1
por: Dove, Katja K., et al.
Publicado: (2017)

Structural Model of the hUbA1-UbcH10 Quaternary Complex: In Silico and Experimental Analysis of the Protein-Protein Interactions between E1, E2 and Ubiquitin
por: Correale, Stefania, et al.
Publicado: (2014)

Incidence of chemotherapy-induced amenorrhea associated with epirubicin, docetaxel and navelbine in younger breast cancer patients
por: Zhou, Wen-Bin, et al.
Publicado: (2010)

Differential immunomodulatory effects of epirubicin/cyclophosphamide and docetaxel in breast cancer patients
por: Wimmer, Kerstin, et al.
Publicado: (2023)

E2(UbcH5B)-derived peptide ligands target HECT E3-E2 binding site and block the Ub-dependent SARS-CoV-2 egression: A computational study
por: Zahid, Sana, et al.
Publicado: (2022)

Weekly epirubicin plus docetaxel as first-line treatment in metastatic breast cancer
por: Gamucci, T, et al.
Publicado: (2007)

Clonal evolution in primary breast cancers under sequential epirubicin and docetaxel monotherapy
por: Venizelos, Andreas, et al.
Publicado: (2022)

Phase II multicentre randomised study of docetaxel plus epirubicin vs 5-fluorouracil plus epirubicin and cyclophosphamide in metastatic breast cancer
por: Bonneterre, J, et al.
Publicado: (2004)

Comparison of the effectiveness and toxicity of neoadjuvant chemotherapy regimens, capecitabine/epirubicin/cyclophosphamide vs 5-fluorouracil/epirubicin/cyclophosphamide, followed by adjuvant, capecitabine/docetaxel vs docetaxel, in patients with operable breast cancer
por: Zhang, Minmin, et al.
Publicado: (2016)

Lentivirus-mediated RNA interference of clusterin enhances the chemosensitivity of EJ bladder cancer cells to epirubicin in vitro
por: Lu, Jian, et al.
Publicado: (2021)

Neoadjuvant rh-endostatin, docetaxel and epirubicin for breast cancer: efficacy and safety in a prospective, randomized, phase II study
por: Chen, Jianghao, et al.
Publicado: (2013)

Docetaxel and epirubicin compared with docetaxel and prednisone in advanced castrate-resistant prostate cancer: a randomised phase II study
por: Petrioli, R, et al.
Publicado: (2011)

Ubc9 expression predicts chemoresistance in breast cancer
por: Chen, Shi-Feng, et al.
Publicado: (2011)

Expression significance of Emi1, UBCH10 and CyclinB1 in esophageal squamous cell carcinoma
por: Li, Hui, et al.
Publicado: (2023)

A dose-finding study of carboplatin–epirubicin–docetaxel in advanced epithelial ovarian cancer
por: O'Neill, V J, et al.
Publicado: (2002)

Combination chemotherapy with epirubicin, docetaxel and cisplatin (EDP) in metastatic or recurrent, unresectable gastric cancer
por: Lee, S-H, et al.
Publicado: (2004)

High Expression of Pyruvate Kinase M2 is Associated with Chemosensitivity to Epirubicin and 5-Fluorouracil in Breast Cancer
por: Lin, Yang, et al.
Publicado: (2015)

Docetaxel, cisplatin, and 5-fluorouracil compared with epirubicin, cisplatin, and 5-fluorouracil regimen for advanced gastric cancer: A systematic review and meta-analysis
por: Li, Bo, et al.
Publicado: (2019)

Knockdown of cullin 4A inhibits growth and increases chemosensitivity in lung cancer cells
por: Hung, Ming‐Szu, et al.
Publicado: (2016)

Girdin Knockdown Increases Gemcitabine Chemosensitivity to Pancreatic Cancer by Modulating Autophagy
por: Wang, Sheng, et al.
Publicado: (2021)

A Phase II Study of Docetaxel and Epirubicin in Advanced Adult Soft Tissue Sarcomas (STS)
por: Kalofonos, Haralabos P., et al.
Publicado: (2004)

Phase II study of epirubicin, oxaliplatin and docetaxel combination in metastatic gastric or gastroesophageal junction adenocarcinoma
por: Di Lauro, Luigi, et al.
Publicado: (2009)

Dose-Dense Epirubicin and Cyclophosphamide Followed by Docetaxel as Adjuvant Chemotherapy in Node-Positive Breast Cancer
por: Mirzaei, Hamid Reza, et al.
Publicado: (2013)

Clinical outcome and predictive factors for docetaxel and epirubicin neoadjuvant chemotherapy of locally advanced breast cancer
por: Won, Hye Sung, et al.
Publicado: (2020)

Arabidopsis Ubiquitin-Conjugating Enzymes UBC7, UBC13, and UBC14 Are Required in Plant Responses to Multiple Stress Conditions
por: Feng, Hui, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_nat4c2itbiaq5eojl7tifscr1f